Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vitamin K supports TGF-β1 depended in vitro human Langerhans cell differentiation and function via Axl. | Front Immunol | 2025 | 40040711 | PubTator, text mining | PubMed |
| Gal-3 activates Tyro3 to ameliorate ferroptosis of hippocampal neurons after traumatic brain injury. | Mol Ther Nucleic Acids | 2025 | 39902149 | PubTator, text mining | PubMed |
| Activated AXL Ameliorates Alcohol-associated Steatotic Liver Ischemia-Reperfusion Injury by Inhibiting ER stress and Mitochondria-associated Apoptosis. | Int J Biol Sci | 2025 | 39897049 | PubTator, text mining | PubMed |
| New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis. | J Pharmacol Exp Ther | 2025 | 39892997 | PubTator, text mining | PubMed |
| Distinct TYRO3 and PROS1 expression levels contribute to preeclampsia pathogenesis. | Histochem Cell Biol | 2025 | 39878883 | PubTator, text mining | PubMed |
| Phytochemicals Withanolide N and Dryobalanolide as Potential Bioactive Leads for Developing Anticancer Drugs Targeting Tyrosine-Protein Kinase Mer. | OMICS | 2025 | 39792454 | PubTator, text mining | PubMed |
| Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients. | Mol Neurobiol | 2025 | 39762711 | PubTator, text mining | PubMed |
| Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis. | Antioxid Redox Signal | 2025 | 39723566 | PubTator, text mining | PubMed |
| The CDK8 kinase module: A novel player in the transcription of translation initiation and ribosomal genes. | Mol Biol Cell | 2025 | 39565680 | PubTator, text mining | PubMed |
| Constructing a Novel Amino Acid Metabolism Signature: A New Perspective on Pheochromocytoma Diagnosis, Immune Landscape, and Immunotherapy. | Biochem Genet | 2025 | 38526709 | PubTator, text mining | PubMed |
| Apoptotic clearance by stem cells: molecular mechanisms for recognition and phagocytosis of dead cells. | Signal Transduct Target Ther | 2024 | 39737922 | PubTator, text mining | PubMed |
| Uncovering the molecular networks of ferroptosis in the pathogenesis of type 2 diabetes and its complications: a multi-omics investigation. | Mol Med | 2024 | 39716081 | PubTator, text mining | PubMed |
| Functions of TAM Receptors and Ligands Protein S and Gas6 in Atherosclerosis and Cardiovascular Disease. | Int J Mol Sci | 2024 | 39684449 | PubTator, text mining | PubMed |
| TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury. | Acta Neuropathol | 2024 | 39680199 | PubTator, text mining | PubMed |
| Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple sclerosis. | J Neuroinflammation | 2024 | 39673059 | PubTator, text mining | PubMed |
| Design and Development of Novel Hybrids Based on Pyrrolo[2,1-f][1,2,4]Triazine and 1-(Methylpiperidin-4-yl) Aniline-Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition. | Chem Biol Drug Des | 2024 | 39635932 | PubTator, text mining | PubMed |
| Intra- and inter-patient diversity in hepatocellular carcinoma based on phosphorylation profiles-A pilot study in a single institution. | Clin Res Hepatol Gastroenterol | 2024 | 39551467 | PubTator, text mining | PubMed |
| Role and Mechanisms of Tyro3 in Podocyte Biology and Glomerular Disease. | Kidney Dis (Basel) | 2024 | 39430290 | PubTator, text mining | PubMed |
| Analysis of the Plasticity of Circulating Tumor Cells Reveals Differentially Regulated Kinases During the Suspension-to-Adherent Transition. | Cancer Med | 2024 | 39425449 | PubTator, text mining | PubMed |
| Germline DNA Damage Repair Gene Alterations in Patients with Metachronous Breast and Colorectal Cancer. | Int J Mol Sci | 2024 | 39408606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=7